IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Genmab
Bristol-Myers Squibb
Neonc Technologies, Inc.
Inhibrx Biosciences, Inc
Toray Industries, Inc
Iovance Biotherapeutics, Inc.
M.D. Anderson Cancer Center
Shanghai Junshi Bioscience Co., Ltd.
GI Innovation, Inc.
Eli Lilly and Company
GlaxoSmithKline
Nektar Therapeutics
Bristol-Myers Squibb
Philogen S.p.A.
M.D. Anderson Cancer Center
Jewish General Hospital
Jewish General Hospital
Merck Sharp & Dohme LLC
University of California, Irvine
University of Zurich
Eli Lilly and Company
University of California, San Francisco
New Mexico Cancer Research Alliance
Genentech, Inc.
Peking University Cancer Hospital & Institute
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
City of Hope Medical Center
Oncolytics Biotech
SCRI Development Innovations, LLC
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp.
University of Virginia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Rutgers, The State University of New Jersey